Regeneron (REGN) Misses Q1 EPS by 64c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $803.90 --0%
Revenue Growth %: +21.1%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +21.1%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $9.55, $0.64 worse than the analyst estimate of $10.19. Revenue for the quarter came in at $3.15 billion versus the consensus estimate of $3.22 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
